GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diagnosticos da America SA (BSP:DASA3) » Definitions » Debt-to-EBITDA

Diagnosticos da America (BSP:DASA3) Debt-to-EBITDA : 10.31 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Diagnosticos da America Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Diagnosticos da America's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was R$1,897 Mil. Diagnosticos da America's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was R$11,397 Mil. Diagnosticos da America's annualized EBITDA for the quarter that ended in Dec. 2023 was R$1,290 Mil. Diagnosticos da America's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 10.31.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Diagnosticos da America's Debt-to-EBITDA or its related term are showing as below:

BSP:DASA3' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.19   Med: 4.23   Max: 9.05
Current: 6.36

During the past 13 years, the highest Debt-to-EBITDA Ratio of Diagnosticos da America was 9.05. The lowest was 2.19. And the median was 4.23.

BSP:DASA3's Debt-to-EBITDA is ranked worse than
87.5% of 104 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.915 vs BSP:DASA3: 6.36

Diagnosticos da America Debt-to-EBITDA Historical Data

The historical data trend for Diagnosticos da America's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnosticos da America Debt-to-EBITDA Chart

Diagnosticos da America Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.31 7.93 9.05 6.29 6.36

Diagnosticos da America Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.60 6.12 6.35 5.13 10.31

Competitive Comparison of Diagnosticos da America's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Diagnosticos da America's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnosticos da America's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diagnosticos da America's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Diagnosticos da America's Debt-to-EBITDA falls into.



Diagnosticos da America Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Diagnosticos da America's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1897.394 + 11397.234) / 2091.485
=6.36

Diagnosticos da America's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1897.394 + 11397.234) / 1289.744
=10.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Diagnosticos da America  (BSP:DASA3) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Diagnosticos da America Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Diagnosticos da America's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnosticos da America (BSP:DASA3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).

Diagnosticos da America (BSP:DASA3) Headlines

No Headlines